Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer

Clinical trial NCT02963610 · TERMINATED

Trial details

NCT number

NCT02963610

Sponsor

Fox Chase Cancer Center

Status

TERMINATED

Phase

Phase 1, Phase 2

Study type

INTERVENTIONAL

Start date

2017-03-29

Primary completion

2017-10-03

Enrollment

3

View on ClinicalTrials.gov